{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:19:47Z","timestamp":1787656787705,"version":"build-2736575974"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82102431"],"award-info":[{"award-number":["82102431"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province, China","doi-asserted-by":"crossref","award":["26JRRA817"],"award-info":[{"award-number":["26JRRA817"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"crossref"}]},{"name":"he Key Incubation Project Funds of The Second Hospital & Clinical Medical School, Lanzhou University","award":["2025-21-zdfy-004"],"award-info":[{"award-number":["2025-21-zdfy-004"]}]},{"name":"Talent Introduction Plan of The Second Hospital & Clinical Medical School, Lanzhou University","award":["yjrckyqdj-2021-03"],"award-info":[{"award-number":["yjrckyqdj-2021-03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12639-4","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:30:11Z","timestamp":1787653811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microbiome and pancreatic ductal adenocarcinoma: mechanistic insights, microenvironmental interactions, and therapeutic implications"],"prefix":"10.1007","volume":"53","author":[{"given":"Huiya","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"12639_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3390\/biomedicines12010227","volume":"12","author":"I Mendes","year":"2024","unstructured":"Mendes I, Vale N (2024) Overcoming microbiome-acquired gemcitabine resistance in pancreatic ductal adenocarcinoma. Biomedicines 12:227. https:\/\/doi.org\/10.3390\/biomedicines12010227","journal-title":"Biomedicines"},{"key":"12639_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.48095\/ccko202420","volume":"37","author":"M Eid","year":"2024","unstructured":"Eid M, Mart\u00ednek A, Dolina J, Uv\u00edrov\u00e1 M, D\u00edt\u011b P (2024) Gut microbiome and pancreatic cancer. Klin Onkol 37:20\u201326. https:\/\/doi.org\/10.48095\/ccko202420","journal-title":"Klin Onkol"},{"key":"12639_CR3","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.trecan.2022.08.005","volume":"8","author":"E Espinet","year":"2022","unstructured":"Espinet E, Klein L, Pur\u00e9 E, Singh SK (2022) Mechanisms of PDAC subtype heterogeneity and therapy response. Trends Cancer 8:1060\u20131071. https:\/\/doi.org\/10.1016\/j.trecan.2022.08.005","journal-title":"Trends Cancer"},{"key":"12639_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41698-024-00681-z","volume":"8","author":"Y Ju","year":"2024","unstructured":"Ju Y, Xu D, Liao M, Sun Y, Bao W, Yao F, Ma L (2024) Barriers and opportunities in pancreatic cancer immunotherapy. npj Precis Oncol 8:1\u201318. https:\/\/doi.org\/10.1038\/s41698-024-00681-z","journal-title":"npj Precis Oncol"},{"key":"12639_CR5","doi-asserted-by":"publisher","first-page":"2213112","DOI":"10.1080\/20002297.2023.2213112","volume":"15","author":"X Tan","year":"2023","unstructured":"Tan X, Wang Y, Gong T (2023) The interplay between oral microbiota, gut microbiota and systemic diseases. J Oral Microbiol 15:2213112. https:\/\/doi.org\/10.1080\/20002297.2023.2213112","journal-title":"J Oral Microbiol"},{"key":"12639_CR6","doi-asserted-by":"publisher","first-page":"188484","DOI":"10.1016\/j.bbcan.2020.188484","volume":"1875","author":"J Dong","year":"2021","unstructured":"Dong J, Gao HL, Wang WQ, Yu XJ, Liu L (2021) Bidirectional and dynamic interaction between the microbiota and therapeutic resistance in pancreatic cancer. Biochim Biophys Acta Rev Cancer 1875:188484. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188484","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"12639_CR7","doi-asserted-by":"publisher","unstructured":"Dhar AK (2023) Human microbiome modulation: a potential therapeutic strategy for pancreatic cancer. In: Mishra N, Bhatt S, Paudel KR, Hansbro PM, Dua K (eds) Synbiotics for the Management of Cancer. Springer Nature, Singapore, pp 205\u2013242. https:\/\/doi.org\/10.1007\/978-981-19-7550-9_10","DOI":"10.1007\/978-981-19-7550-9_10"},{"key":"12639_CR8","doi-asserted-by":"publisher","first-page":"604531","DOI":"10.3389\/fonc.2020.604531","volume":"10","author":"W Zhang","year":"2021","unstructured":"Zhang W, Zhang K, Zhang P, Zheng J, Min C, Li X (2021) Research progress of pancreas-related microorganisms and pancreatic cancer. Front Oncol 10:604531. https:\/\/doi.org\/10.3389\/fonc.2020.604531","journal-title":"Front Oncol"},{"key":"12639_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/JP9.0000000000000057","volume":"3","author":"P Sharma","year":"2020","unstructured":"Sharma P, Jain T, Sethi V, Iyer S, Dudeja V (2020) Gut microbiome: the third musketeer in the cancer-immune system cross-talk. J Pancreatol 3:181. https:\/\/doi.org\/10.1097\/JP9.0000000000000057","journal-title":"J Pancreatol"},{"key":"12639_CR10","doi-asserted-by":"publisher","first-page":"107214","DOI":"10.1016\/j.micpath.2024.107214","volume":"199","author":"WM Jankowski","year":"2025","unstructured":"Jankowski WM, Fichna J, Tarasiuk-Zawadzka A (2025) A systematic review of the relationship between gut microbiota and prevalence of pancreatic diseases. Microb Pathog 199:107214. https:\/\/doi.org\/10.1016\/j.micpath.2024.107214","journal-title":"Microb Pathog"},{"key":"12639_CR11","doi-asserted-by":"publisher","first-page":"844401","DOI":"10.3389\/fimmu.2022.844401","volume":"13","author":"Z Chen","year":"2022","unstructured":"Chen Z, Zhang S, Dong S, Xu H, Zhou W (2022) Association of the microbiota and pancreatic cancer: opportunities and limitations. Front Immunol 13:844401. https:\/\/doi.org\/10.3389\/fimmu.2022.844401","journal-title":"Front Immunol"},{"key":"12639_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10555-022-10022-w","volume":"41","author":"RE Sexton","year":"2022","unstructured":"Sexton RE, Uddin MH, Bannoura S, Khan HY, Mzannar Y, Li Y, Aboukameel A, Al-Hallak MN, Al-Share B, Mohamed A, Nagasaka M, El-Rayes B, Azmi AS (2022) Connecting the human microbiome and pancreatic cancer. Cancer Metastasis Rev 41:317\u2013331. https:\/\/doi.org\/10.1007\/s10555-022-10022-w","journal-title":"Cancer Metastasis Rev"},{"key":"12639_CR13","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.7150\/jca.37445","volume":"11","author":"X Zhang","year":"2020","unstructured":"Zhang X, Liu Q, Liao Q, Zhao Y (2020) Pancreatic cancer, gut microbiota, and therapeutic efficacy. J Cancer 11:2749\u20132758. https:\/\/doi.org\/10.7150\/jca.37445","journal-title":"J Cancer"},{"key":"12639_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40364-022-00381-5","volume":"10","author":"J Liu","year":"2022","unstructured":"Liu J, Zhang Y (2022) Intratumor microbiome in cancer progression: current developments, challenges and future trends. Biomark Res 10:37. https:\/\/doi.org\/10.1186\/s40364-022-00381-5","journal-title":"Biomark Res"},{"key":"12639_CR15","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1158\/1055-9965.EPI-18-0542","volume":"28","author":"E Del Castillo","year":"2019","unstructured":"Del Castillo E, Meier R, Chung M, Koestler DC, Chen T, Paster BJ, Charpentier KP, Kelsey KT, Izard J, Michaud DS (2019) The microbiomes of pancreatic and duodenum tissue overlap and are highly subject specific but differ between pancreatic cancer and noncancer subjects. Cancer Epidemiol Biomarkers Prev 28:370\u2013383. https:\/\/doi.org\/10.1158\/1055-9965.EPI-18-0542","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"12639_CR16","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1136\/gutjnl-2021-324031","volume":"71","author":"FC Gleeson","year":"2022","unstructured":"Gleeson FC, Jeraldo P, Levy MJ, Murphy SJ, Mendes-Soares H, Karagouga G, McCune AF, Garcia Garcia de Paredes A, Kipp BR, Song SD, Khanna S, Pardi DS, Chia N (2022) Composition, diversity and potential utility of intervention-na\u00efve pancreatic cancer intratumoral microbiome signature profiling via endoscopic ultrasound. Gut 71:441\u2013443. https:\/\/doi.org\/10.1136\/gutjnl-2021-324031","journal-title":"Gut"},{"key":"12639_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.it.2012.05.003","volume":"33","author":"C Ubeda","year":"2012","unstructured":"Ubeda C, Pamer EG (2012) Antibiotics, microbiota, and immune defense. Trends Immunol 33:459\u2013466. https:\/\/doi.org\/10.1016\/j.it.2012.05.003","journal-title":"Trends Immunol"},{"key":"12639_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12943-019-1008-0","volume":"18","author":"MY Wei","year":"2019","unstructured":"Wei MY, Shi S, Liang C, Meng QC, Hua J, Zhang YY, Liu J, Zhang B, Xu J, Yu XJ (2019) The microbiota and microbiome in pancreatic cancer: more influential than expected. Mol Cancer 18:97. https:\/\/doi.org\/10.1186\/s12943-019-1008-0","journal-title":"Mol Cancer"},{"key":"12639_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1053\/j.gastro.2022.03.054","volume":"163","author":"N Nagata","year":"2022","unstructured":"Nagata N, Nishijima S, Kojima Y, Hisada Y, Imbe K, Miyoshi-Akiyama T, Suda W, Kimura M, Aoki R, Sekine K, Ohsugi M, Miki K, Osawa T, Ueki K, Oka S, Mizokami M, Kartal E, Schmidt TSB, Molina-Montes E, Estudillo L, Malats N, Trebicka J, Kersting S, Langheinrich M, Bork P, Uemura N, Itoi T, Kawai T (2022) Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study. Gastroenterology 163:222\u2013238. https:\/\/doi.org\/10.1053\/j.gastro.2022.03.054","journal-title":"Gastroenterology"},{"key":"12639_CR20","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrmicro3344","volume":"12","author":"P Louis","year":"2014","unstructured":"Louis P, Hold GL, Flint HJ (2014) The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 12:661\u2013672. https:\/\/doi.org\/10.1038\/nrmicro3344","journal-title":"Nat Rev Microbiol"},{"key":"12639_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1574-6968.2009.01514.x","volume":"294","author":"P Louis","year":"2009","unstructured":"Louis P, Flint HJ (2009) Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 294:1\u20138. https:\/\/doi.org\/10.1111\/j.1574-6968.2009.01514.x","journal-title":"FEMS Microbiol Lett"},{"key":"12639_CR22","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, Takahashi M, Fukuda NN, Murakami S, Miyauchi E, Hino S, Atarashi K, Onawa S, Fujimura Y, Lockett T, Clarke JM, Topping DL, Tomita M, Hori S, Ohara O, Morita T, Koseki H, Kikuchi J, Honda K, Hase K, Ohno H (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:446\u2013450. https:\/\/doi.org\/10.1038\/nature12721","journal-title":"Nature"},{"key":"12639_CR23","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1073\/pnas.1322269111","volume":"111","author":"PV Chang","year":"2014","unstructured":"Chang PV, Hao L, Offermanns S, Medzhitov R (2014) The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA 111:2247\u20132252. https:\/\/doi.org\/10.1073\/pnas.1322269111","journal-title":"Proc Natl Acad Sci USA"},{"key":"12639_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D, De la Fuente MK, Landskron G, Gonz\u00e1lez MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, Hermoso MA (2019) Short-chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 10:277. https:\/\/doi.org\/10.3389\/fimmu.2019.00277","journal-title":"Front Immunol"},{"key":"12639_CR25","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1002\/cam4.5323","volume":"12","author":"HY Temel","year":"2023","unstructured":"Temel HY, Kaymak \u00d6, Kaplan S, Bahcivanci B, Gkoutos GV, Acharjee A (2023) Role of microbiota and microbiota-derived short-chain fatty acids in PDAC. Cancer Med 12:5661\u20135675. https:\/\/doi.org\/10.1002\/cam4.5323","journal-title":"Cancer Med"},{"key":"12639_CR26","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1136\/gutjnl-2021-324755","volume":"71","author":"E Kartal","year":"2022","unstructured":"Kartal E, Schmidt TSB, Molina-Montes E, Rodr\u00edguez-Perales S, Wirbel J, Maistrenko OM, Akanni WA, Alashkar Alhamwe B, Alves RJ, Carrato A, Erasmus HP, Estudillo L, Finkelmeier F, Fullam A, Glazek AM, G\u00f3mez-Rubio P, Hercog R, Jung F, Kandels S, Kersting S, Langheinrich M, M\u00e1rquez M, Molero X, Orakov A, Van Rossum T, Torres-Ruiz R, Telzerow A, Zych K, Benes V, Zeller G, Trebicka J, Real FX, Malats N, Bork P, PanGenEU Study investigators (2022) A faecal microbiota signature with high specificity for pancreatic cancer. Gut 71:1359\u20131372. https:\/\/doi.org\/10.1136\/gutjnl-2021-324755","journal-title":"Gut"},{"key":"12639_CR27","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3390\/cancers12051068","volume":"12","author":"B Kiss","year":"2020","unstructured":"Kiss B, Mik\u00f3 E, Seb\u0151 \u00c9, T\u00f3th J, Ujlaki G, Szab\u00f3 J, Uray K, Bai P, \u00c1rkosy P (2020) Oncobiosis and microbial metabolite signaling in pancreatic adenocarcinoma. Cancers (Basel) 12:1068. https:\/\/doi.org\/10.3390\/cancers12051068","journal-title":"Cancers (Basel)"},{"key":"12639_CR28","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/MPA.0000000000001797","volume":"50","author":"B Liu","year":"2021","unstructured":"Liu B, Wang F, Chen L, Xin Y, Liu L, Wu D, Li W (2021) Effects of high-fat diet on carcinogen-induced pancreatic cancer and intestinal microbiota in C57BL\/6 wild-type mice. Pancreas 50:564\u2013570. https:\/\/doi.org\/10.1097\/MPA.0000000000001797","journal-title":"Pancreas"},{"key":"12639_CR29","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3390\/life14101219","volume":"14","author":"KA Rumyantsev","year":"2024","unstructured":"Rumyantsev KA, Polyakova VV, Sorokina IV, Feoktistova PS, Khatkov IE, Bodunova NA, Zhukova LG (2024) The gut microbiota impacts gastrointestinal cancers through obesity, diabetes, and chronic inflammation. Life (Basel) 14:1219. https:\/\/doi.org\/10.3390\/life14101219","journal-title":"Life (Basel)"},{"key":"12639_CR30","doi-asserted-by":"publisher","first-page":"740636","DOI":"10.3389\/fphar.2021.740636","volume":"12","author":"TU Maioli","year":"2021","unstructured":"Maioli TU, Borras-Nogues E, Torres L, Barbosa SC, Martins VD, Langella P, Azevedo VA, Chatel JM (2021) Possible benefits of Faecalibacterium prausnitzii for obesity-associated gut disorders. Front Pharmacol 12:740636. https:\/\/doi.org\/10.3389\/fphar.2021.740636","journal-title":"Front Pharmacol"},{"key":"12639_CR31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.pan.2023.12.010","volume":"24","author":"T Yoshida","year":"2024","unstructured":"Yoshida T, Dbouk M, Hirose K, Abou Diwan E, Saba H, Dbouk A, Goggins M (2024) Duodenal and pancreatic tissue microbiome profiles of PPI users and non-users. Pancreatology 24:188\u2013195. https:\/\/doi.org\/10.1016\/j.pan.2023.12.010","journal-title":"Pancreatology"},{"key":"12639_CR32","doi-asserted-by":"publisher","first-page":"e196","DOI":"10.1016\/j.cgh.2020.11.006","volume":"20","author":"S Kohi","year":"2022","unstructured":"Kohi S, Macgregor-Das A, Dbouk M, Yoshida T, Chuidian M, Abe T, Borges M, Lennon AM, Shin EJ, Canto MI, Goggins M (2022) Alterations in the duodenal fluid microbiome of patients with pancreatic cancer. Clin Gastroenterol Hepatol 20:e196\u2013e227. https:\/\/doi.org\/10.1016\/j.cgh.2020.11.006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"12639_CR33","doi-asserted-by":"publisher","first-page":"e38531","DOI":"10.1097\/MD.0000000000038531","volume":"103","author":"D Jin","year":"2024","unstructured":"Jin D, Jin S, Zhou T, Cui Z, Guo B, Li G, Zhang C (2024) Quantitative evaluation of gut microbiota composition in pancreatic cancer: a pooled study. Med (Baltim) 103:e38531. https:\/\/doi.org\/10.1097\/MD.0000000000038531","journal-title":"Med (Baltim)"},{"key":"12639_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12967-021-02882-7","volume":"19","author":"W Zhou","year":"2021","unstructured":"Zhou W, Zhang D, Li Z, Jiang H, Li J, Ren R, Gao X, Li J, Wang X, Wang W, Yang Y (2021) The fecal microbiota of patients with pancreatic ductal adenocarcinoma and autoimmune pancreatitis characterized by metagenomic sequencing. J Transl Med 19:215. https:\/\/doi.org\/10.1186\/s12967-021-02882-7","journal-title":"J Transl Med"},{"key":"12639_CR35","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.7150\/jca.52943","volume":"13","author":"X Guo","year":"2022","unstructured":"Guo X, Hu Z, Rong S, Xie G, Nie G, Liu X, Jin G (2022) Integrative analysis of metabolome and gut microbiota in patients with pancreatic ductal adenocarcinoma. J Cancer 13:1555\u20131564. https:\/\/doi.org\/10.7150\/jca.52943","journal-title":"J Cancer"},{"key":"12639_CR36","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.pan.2024.09.002","volume":"24","author":"M Sono","year":"2024","unstructured":"Sono M, Iimori K, Nagao M, Ogawa S, Maruno T, Nakanishi Y, Anazawa T, Nagai K, Masui T, Mori H, Hosomi K, Kunisawa J, Yokota H, Tanaka Y, Ohno H, Hatano E, Fukuda A, Seno H (2024) Reduction of butyrate-producing bacteria in the gut microbiome of Japanese patients with pancreatic cancer. Pancreatology 24:1031\u20131039. https:\/\/doi.org\/10.1016\/j.pan.2024.09.002","journal-title":"Pancreatology"},{"key":"12639_CR37","doi-asserted-by":"publisher","first-page":"1184869","DOI":"10.3389\/fmicb.2023.1184869","volume":"14","author":"J Yang","year":"2023","unstructured":"Yang J, Ma Y, Tan Q, Zhou B, Yu D, Jin M, Zhang T, Liu J, Liu H (2023) Gut Streptococcus is a microbial marker for the occurrence and liver metastasis of pancreatic cancer. Front Microbiol 14:1184869. https:\/\/doi.org\/10.3389\/fmicb.2023.1184869","journal-title":"Front Microbiol"},{"key":"12639_CR38","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1111\/cas.16238","volume":"115","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Liang X, Zhang G, Li F, Xu J, Ma R, Chen X, Ma M, Wang Y, Chen C, Tang H, Li L, Li Z (2024) Microbiota and metabolite alterations in pancreatic head and body\/tail cancer patients. Cancer Sci 115:2738\u20132750. https:\/\/doi.org\/10.1111\/cas.16238","journal-title":"Cancer Sci"},{"key":"12639_CR39","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00535-023-02069-5","volume":"59","author":"S Abe","year":"2024","unstructured":"Abe S, Masuda A, Matsumoto T, Inoue J, Toyama H, Sakai A, Kobayashi T, Tanaka T, Tsujimae M, Yamakawa K, Gonda M, Masuda S, Uemura H, Kohashi S, Inomata N, Nagao K, Harada Y, Miki M, Irie Y, Juri N, Ko T, Yokotani Y, Oka Y, Ota S, Kanzawa M, Itoh T, Imai T, Fukumoto T, Hara E, Kodama Y (2024) Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma. J Gastroenterol 59:250\u2013262. https:\/\/doi.org\/10.1007\/s00535-023-02069-5","journal-title":"J Gastroenterol"},{"key":"12639_CR40","doi-asserted-by":"publisher","first-page":"10988","DOI":"10.3390\/ijms252010988","volume":"25","author":"L Vil\u00e0-Quintana","year":"2024","unstructured":"Vil\u00e0-Quintana L, Fort E, Pardo L, Albiol-Quer MT, Ortiz MR, Capdevila M, Feliu A, Bah\u00ed A, Llir\u00f3s M, Garc\u00eda-Velasco A, Morell Ginest\u00e0 M, Laquente B, Pozas D, Moreno V, Garcia-Gil LJ, Duell EJ, Pimenoff VN, Carreras-Torres R, Aldeguer X (2024) Metagenomic study reveals phage-bacterial interactome dynamics in gut and oral microbiota in pancreatic diseases. Int J Mol Sci 25:10988. https:\/\/doi.org\/10.3390\/ijms252010988","journal-title":"Int J Mol Sci"},{"key":"12639_CR41","doi-asserted-by":"publisher","first-page":"7679","DOI":"10.3748\/wjg.v26.i48.7679","volume":"26","author":"AL Wei","year":"2020","unstructured":"Wei AL, Li M, Li GQ, Wang X, Hu WM, Li ZL, Yuan J, Liu HY, Zhou LL, Li K, Li A, Fu MR (2020) Oral microbiome and pancreatic cancer. World J Gastroenterol 26:7679\u20137692. https:\/\/doi.org\/10.3748\/wjg.v26.i48.7679","journal-title":"World J Gastroenterol"},{"key":"12639_CR42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12866-023-03166-4","volume":"24","author":"G Pourali","year":"2024","unstructured":"Pourali G, Kazemi D, Chadeganipour AS, Arastoonejad M, Kashani SN, Pourali R, Maftooh M, Akbarzadeh H, Fiuji H, Hassanian SM, Ghayour-Mobarhan M, Ferns GA, Khazaei M, Avan A (2024) Microbiome as a biomarker and therapeutic target in pancreatic cancer. BMC Microbiol 24:16. https:\/\/doi.org\/10.1186\/s12866-023-03166-4","journal-title":"BMC Microbiol"},{"key":"12639_CR43","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1097\/JS9.0000000000001762","volume":"110","author":"N Merali","year":"2024","unstructured":"Merali N, Chouari T, Sweeney C, Halle-Smith J, Jessel MD, Wang B, O\u2019Brien J, Suyama S, Jim\u00e9nez JI, Roberts KJ, Velliou E, Sivakumar S, Rockall TA, Demirkan A, Pedicord V, Deng D, Giovannetti E, Annels NE, Frampton AE (2024) The microbial composition of pancreatic ductal adenocarcinoma: a systematic review of 16S rRNA gene sequencing. Int J Surg 110:6771\u20136799. https:\/\/doi.org\/10.1097\/JS9.0000000000001762","journal-title":"Int J Surg"},{"key":"12639_CR44","doi-asserted-by":"publisher","first-page":"2374596","DOI":"10.1080\/19490976.2024.2374596","volume":"16","author":"J de Castilhos","year":"2024","unstructured":"de Castilhos J, Tillmanns K, Blessing J, Lara\u00f1o A, Borisov V, Stein-Thoeringer CK (2024) Microbiome and pancreatic cancer: time to think about chemotherapy. Gut Microbes 16:2374596. https:\/\/doi.org\/10.1080\/19490976.2024.2374596","journal-title":"Gut Microbes"},{"key":"12639_CR45","doi-asserted-by":"publisher","first-page":"170","DOI":"10.14218\/CSP.2024.00017","volume":"3","author":"X Hu","year":"2024","unstructured":"Hu X, Ma C, Kong X (2024) Gut dysbiosis and fecal microbiota transplantation in pancreatic cancer: current status and perspectives. Cancer Screen Prev 3:170\u2013183. https:\/\/doi.org\/10.14218\/CSP.2024.00017","journal-title":"Cancer Screen Prev"},{"key":"12639_CR46","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13041-024-01091-9","volume":"17","author":"Y Suda","year":"2024","unstructured":"Suda Y, Nakamura K, Matsuyama F, Hamada Y, Makabe H, Narita M, Nagumo Y, Mori T, Kuzumaki N, Narita M (2024) Peripheral-central network analysis of cancer cachexia status accompanied by the polarization of hypothalamic microglia with low expression of inhibitory immune checkpoint receptors. Mol Brain 17:20. https:\/\/doi.org\/10.1186\/s13041-024-01091-9","journal-title":"Mol Brain"},{"key":"12639_CR47","doi-asserted-by":"publisher","first-page":"1158200","DOI":"10.3389\/fimmu.2023.1158200","volume":"14","author":"Y Dong","year":"2023","unstructured":"Dong Y, Zhang K, Wei J, Ding Y, Wang X, Hou H, Wu J, Liu T, Wang B, Cao H (2023) Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy? Front Immunol 14:1158200. https:\/\/doi.org\/10.3389\/fimmu.2023.1158200","journal-title":"Front Immunol"},{"key":"12639_CR48","doi-asserted-by":"publisher","first-page":"127871","DOI":"10.1016\/j.micres.2024.127871","volume":"288","author":"T Yin","year":"2024","unstructured":"Yin T, Zhang X, Xiong Y, Li B, Guo D, Sha Z, Lin X, Wu H (2024) Exploring gut microbial metabolites as key players in inhibition of cancer progression: mechanisms and therapeutic implications. Microbiol Res 288:127871. https:\/\/doi.org\/10.1016\/j.micres.2024.127871","journal-title":"Microbiol Res"},{"key":"12639_CR49","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1126\/science.1198469","volume":"331","author":"K Atarashi","year":"2011","unstructured":"Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337\u2013341. https:\/\/doi.org\/10.1126\/science.1198469","journal-title":"Science"},{"key":"12639_CR50","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1128\/AEM.06192-11","volume":"78","author":"S Lebeer","year":"2012","unstructured":"Lebeer S, Claes IJJ, Tytgat HLP, Verhoeven TLA, Marien E, von Ossowski I, Reunanen J, Palva A, de Vos WM, Keersmaecker SCJ, Vanderleyden J (2012) Functional analysis of Lactobacillus rhamnosus GG pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells. Appl Environ Microbiol 78:185\u2013193. https:\/\/doi.org\/10.1128\/AEM.06192-11","journal-title":"Appl Environ Microbiol"},{"key":"12639_CR51","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","volume":"38","author":"AS Bear","year":"2020","unstructured":"Bear AS, Vonderheide RH, O\u2019Hara MH (2020) Challenges and opportunities for pancreatic cancer immunotherapy. Cancer Cell 38:788\u2013802. https:\/\/doi.org\/10.1016\/j.ccell.2020.08.004","journal-title":"Cancer Cell"},{"key":"12639_CR52","doi-asserted-by":"publisher","first-page":"e220111","DOI":"10.1530\/JOE-22-0111","volume":"256","author":"S Fujisaka","year":"2023","unstructured":"Fujisaka S, Watanabe Y, Tobe K (2023) The gut microbiome: a core regulator of metabolism. J Endocrinol 256:e220111. https:\/\/doi.org\/10.1530\/JOE-22-0111","journal-title":"J Endocrinol"},{"key":"12639_CR53","doi-asserted-by":"publisher","first-page":"76","DOI":"10.23736\/S2724-542X.21.02759-2","volume":"33","author":"Y Bahman","year":"2021","unstructured":"Bahman Y, Mohammadlou M, Aisa B, Falalyeyeva T, Kobyliak N, Eslami M (2021) Immunomodulatory role of Faecalibacterium prausnitzii in obesity and metabolic disorders. Minerva Biotechnol Biomol Res 33:76\u201385. https:\/\/doi.org\/10.23736\/S2724-542X.21.02759-2","journal-title":"Minerva Biotechnol Biomol Res"},{"key":"12639_CR54","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.3390\/cancers15112898","volume":"15","author":"Z Nouri","year":"2023","unstructured":"Nouri Z, Choi SW, Choi IJ, Ryu KW, Woo SM, Park SJ, Lee WJ, Choi W, Jung YS, Myung SK, Lee JH, Park JY, Praveen Z, Woo YJ, Park JH, Kim MK (2023) Exploring connections between oral microbiota, short-chain fatty acids, and specific cancer types: a study of oral cancer, head and neck cancer, pancreatic cancer, and gastric cancer. Cancers (Basel) 15:2898. https:\/\/doi.org\/10.3390\/cancers15112898","journal-title":"Cancers (Basel)"},{"key":"12639_CR55","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.3390\/ijms17122060","volume":"17","author":"T Grimmig","year":"2016","unstructured":"Grimmig T, Moench R, Kreckel J, Haack S, Rueckert F, Rehder R, Tripathi S, Ribas C, Chandraker A, Germer CT, Gasser M, Waaga-Gasser AM (2016) Toll-like receptor 2, 4, and 9 signaling promotes autoregulative tumor cell growth and VEGF\/PDGF expression in human pancreatic cancer. Int J Mol Sci 17:2060. https:\/\/doi.org\/10.3390\/ijms17122060","journal-title":"Int J Mol Sci"},{"key":"12639_CR56","doi-asserted-by":"publisher","first-page":"928846","DOI":"10.3389\/fmicb.2022.928846","volume":"13","author":"R Li","year":"2022","unstructured":"Li R, Hu Y, Hou S (2022) An exploration of oral-gut pathogens mediating immune escape of pancreatic cancer via miR-21\/PTEN axis. Front Microbiol 13:928846. https:\/\/doi.org\/10.3389\/fmicb.2022.928846","journal-title":"Front Microbiol"},{"key":"12639_CR57","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1186\/s12885-023-11557-z","volume":"23","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Yi B, Tang Z, Chen X, Li M, Xu T, Zhao Z, Tang C (2023) Lactobacillus casei combined with Lactobacillus reuteri alleviate pancreatic cancer by inhibiting TLR4 to promote macrophage M1 polarization and regulate gut microbial homeostasis. BMC Cancer 23:1044. https:\/\/doi.org\/10.1186\/s12885-023-11557-z","journal-title":"BMC Cancer"},{"key":"12639_CR58","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-5804694\/v1","author":"L Dong","year":"2025","unstructured":"Dong L, Chen Y, Nian F, Wu S, Liu W, Tang W, Zhang D, Wang F, Shen X, Hu X (2025) Low-protein diet enhances anti-tumor immunity and immunotherapy through microbiota-derived uridine diphosphate-galactose in pancreatic cancer. Res Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-5804694\/v1","journal-title":"Res Sq"},{"key":"12639_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22108\/bjm.2020.120382.1251","volume":"13","author":"R Yeganeh","year":"2021","unstructured":"Yeganeh R, Tajabadi Ebrahimi M, Ramezani M (2021) The effects of native Lactobacillus paracasei supernatant solution on death of pancreatic adenocarcinoma cells (AsPC-1) and expression of bax, bcl2, and DPC4 apoptotic genes. Iran J Microbiol 13:1\u20138. https:\/\/doi.org\/10.22108\/bjm.2020.120382.1251","journal-title":"Iran J Microbiol"},{"key":"12639_CR60","doi-asserted-by":"publisher","first-page":"25638","DOI":"10.1021\/acs.jafc.4c06475","volume":"72","author":"H Li","year":"2024","unstructured":"Li H, Li C, Ren M, Zhang F, Cao L, Ren K, Ren H (2024) Fasting-mimicking diet prevents pancreatic carcinogenesis via gut microbiota and metabolites. J Agric Food Chem 72:25638\u201325647. https:\/\/doi.org\/10.1021\/acs.jafc.4c06475","journal-title":"J Agric Food Chem"},{"issue":"12Suppl","key":"12639_CR61","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1158\/1538-7445.AM2022-3046","volume":"82","author":"V Sethi","year":"2022","unstructured":"Sethi V, Tao J, Kurtom S, Vaish U, Afaq F, Zao S, Luo X, Jain T, Sharma P, Bava E, Ramakrishnan S, Li L, Saluja A, Dudeja V (2022) Abstract 3046: A common gut commensal utilizes tryptophan to promote cancer via the aryl hydrocarbon receptor. Cancer Res 82(12Suppl):3046. https:\/\/doi.org\/10.1158\/1538-7445.AM2022-3046","journal-title":"Cancer Res"},{"key":"12639_CR62","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s12672-025-02761-3","volume":"16","author":"F Chen","year":"2025","unstructured":"Chen F, Zhou Y, Mao X, Lin R, Huang H (2025) A systematic Mendelian randomized study of the effects of the gut microbiome and immune cells on pancreatic neuroendocrine tumors. Discov Oncol 16:961. https:\/\/doi.org\/10.1007\/s12672-025-02761-3","journal-title":"Discov Oncol"},{"key":"12639_CR63","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","volume":"149","author":"H Ying","year":"2012","unstructured":"Ying H, Kimmelman AC, Lyssiotis CA, Hua S, Chu GC, Fletcher-Sananikone E, Locasale JW, Son J, Zhang H, Coloff JL, Yan H, Wang W, Chen S, Viale A, Zheng H, Paik J, Lim C, Guimaraes AR, Martin ES, Chang J, Hezel AF, Perry SR, Hu J, Gan B, Xiao Y, Asara JM, Weissleder R, Wang YA, Chin L, Cantley LC, DePinho RA (2012) Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell 149:656\u2013670. https:\/\/doi.org\/10.1016\/j.cell.2012.01.058","journal-title":"Cell"},{"key":"12639_CR64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41392-025-02546-8","volume":"11","author":"U Chianese","year":"2026","unstructured":"Chianese U, Papulino C, Saggese G, Ali A, Ciotola M, Lonardo E, Cortese M, Favale G, Di Mauro A, La Gioia D, Golino V, Sommella E, Campiglia P, Franco R, Ciardiello F, De Vita F, Carafa V, Altucci L, Benedetti R (2026) Glycolytic heterogeneity drives metabolic-targeted therapy in pancreatic ductal adenocarcinoma. Signal Transduct Target Ther 11:25. https:\/\/doi.org\/10.1038\/s41392-025-02546-8","journal-title":"Signal Transduct Target Ther"},{"key":"12639_CR65","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.tcb.2025.04.007","volume":"35","author":"R Thakur","year":"2025","unstructured":"Thakur R, Mullen NJ, Mehla K, Singh PK (2025) Tumor-stromal metabolic crosstalk in pancreatic cancer. Trends Cell Biol 35:1068\u20131083. https:\/\/doi.org\/10.1016\/j.tcb.2025.04.007","journal-title":"Trends Cell Biol"},{"key":"12639_CR66","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.3390\/cancers15143573","volume":"15","author":"P Malhotra","year":"2023","unstructured":"Malhotra P, Palanisamy R, Caparros-Martin JA, Falasca M (2023) Bile acids and microbiota interplay in pancreatic cancer. Cancers (Basel) 15:3573. https:\/\/doi.org\/10.3390\/cancers15143573","journal-title":"Cancers (Basel)"},{"key":"12639_CR67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tem.2024.06.016","volume":"36","author":"P Song","year":"2025","unstructured":"Song P, Peng Z, Guo X (2025) Gut microbial metabolites in cancer therapy. Trends Endocrinol Metab 36:55\u201369. https:\/\/doi.org\/10.1016\/j.tem.2024.06.016","journal-title":"Trends Endocrinol Metab"},{"key":"12639_CR68","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3390\/nu9040331","volume":"9","author":"C Panebianco","year":"2017","unstructured":"Panebianco C, Adamberg K, Adamberg S, Saracino C, Jaagura M, Kolk K, Di Chio AG, Graziano P, Vilu R, Pazienza V (2017) Engineered resistant-starch (ERS) diet shapes colon microbiota profile in parallel with the retardation of tumor growth in vitro and in vivo pancreatic cancer models. Nutrients 9:331. https:\/\/doi.org\/10.3390\/nu9040331","journal-title":"Nutrients"},{"key":"12639_CR69","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","volume":"12","author":"M Luu","year":"2021","unstructured":"Luu M, Riester Z, Baldrich A, Reichardt N, Yuille S, Busetti A, Klein M, Wempe A, Leister H, Raifer H, Picard F, Muhammad K, Ohl K, Romero R, Fischer F, Bauer CA, Huber M, Gress TM, Lauth M, Danhof S, Bopp T, Nerreter T, Mulder IE, Steinhoff U, Hudecek M, Visekruna A (2021) Microbial short-chain fatty acids modulate CD8\u2009+\u2009T cell responses and improve adoptive immunotherapy for cancer. Nat Commun 12:4077. https:\/\/doi.org\/10.1038\/s41467-021-24331-1","journal-title":"Nat Commun"},{"key":"12639_CR70","doi-asserted-by":"publisher","first-page":"e46571","DOI":"10.1371\/journal.pone.0046571","volume":"7","author":"P Sonveaux","year":"2012","unstructured":"Sonveaux P, Copetti T, De Saedeleer CJ, V\u00e9gran F, Verrax J, Kennedy KM, Moon EJ, Dhup S, Danhier P, Fr\u00e9rart F, Gallez B, Ribeiro A, Michiels C, Dewhirst MW, Feron O (2012) Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cells. PLoS ONE 7:e46571. https:\/\/doi.org\/10.1371\/journal.pone.0046571","journal-title":"PLoS ONE"},{"key":"12639_CR71","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fnut.2014.00027","volume":"1","author":"ML Goodwin","year":"2015","unstructured":"Goodwin ML, Gladden LB, Nijsten MWN, Jones KB (2015) Lactate and cancer: revisiting the Warburg effect in an era of lactate shuttling. Front Nutr 1:27. https:\/\/doi.org\/10.3389\/fnut.2014.00027","journal-title":"Front Nutr"},{"key":"12639_CR72","doi-asserted-by":"publisher","first-page":"8388","DOI":"10.1038\/s41598-020-65193-9","volume":"10","author":"AM Kozlov","year":"2020","unstructured":"Kozlov AM, Lone A, Betts DH, Cumming RC (2020) Lactate preconditioning promotes a HIF-1\u03b1-mediated metabolic shift from OXPHOS to glycolysis in normal human diploid fibroblasts. Sci Rep 10:8388. https:\/\/doi.org\/10.1038\/s41598-020-65193-9","journal-title":"Sci Rep"},{"key":"12639_CR73","doi-asserted-by":"publisher","first-page":"1563303","DOI":"10.3389\/fimmu.2025.1563303","volume":"16","author":"XY Gu","year":"2025","unstructured":"Gu XY, Yang JL, Lai R, Zhou ZJ, Tang D, Hu L, Zhao LJ (2025) Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives. Front Immunol 16:1563303. https:\/\/doi.org\/10.3389\/fimmu.2025.1563303","journal-title":"Front Immunol"},{"key":"12639_CR74","doi-asserted-by":"publisher","first-page":"e163022","DOI":"10.1172\/jci.insight.163022","volume":"8","author":"F Kitamura","year":"2023","unstructured":"Kitamura F, Semba T, Yasuda-Yoshihara N, Yamada K, Nishimura A, Yamasaki J, Nagano O, Yasuda T, Yonemura A, Tong Y, Wang H, Akiyama T, Matsumura K, Uemura N, Itoyama R, Bu L, Fu L, Hu X, Wei F, Mima K, Imai K, Hayashi H, Yamashita Y, Miyamoto Y, Baba H, Ishimoto T (2023) Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer. JCI Insight 8:e163022. https:\/\/doi.org\/10.1172\/jci.insight.163022","journal-title":"JCI Insight"},{"key":"12639_CR75","doi-asserted-by":"publisher","first-page":"894853","DOI":"10.3389\/fimmu.2023.894853","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang Z, Dai Z, Zhang H, Liang X, Zhang X, Wen Z, Luo P, Zhang J, Liu Z, Zhang M, Cheng Q (2023) Tumor-secreted lactate contributes to an immunosuppressive microenvironment and affects CD8 T-cell infiltration in glioblastoma. Front Immunol 14:894853. https:\/\/doi.org\/10.3389\/fimmu.2023.894853","journal-title":"Front Immunol"},{"key":"12639_CR76","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13062-024-00513-x","volume":"19","author":"L Zhu","year":"2024","unstructured":"Zhu L, Chen G, Huang C, Gao H, Wang Y, Shen Y (2024) SUMO3 inhibition by butyric acid suppresses cell viability and glycolysis and promotes gemcitabine antitumor activity in pancreatic cancer. Biol Direct 19:74. https:\/\/doi.org\/10.1186\/s13062-024-00513-x","journal-title":"Biol Direct"},{"key":"12639_CR77","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/carcin\/bgae011","volume":"45","author":"Y Ohara","year":"2024","unstructured":"Ohara Y, Craig AJ, Liu H, Yang S, Moreno P, Dorsey TH, Cawley H, Azizian A, Gaedcke J, Ghadimi M, Hanna N, Ambs S, Hussain SP (2024) LMO3 is a suppressor of the basal-like\/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism. Carcinogenesis 45:475\u2013486. https:\/\/doi.org\/10.1093\/carcin\/bgae011","journal-title":"Carcinogenesis"},{"key":"12639_CR78","doi-asserted-by":"publisher","first-page":"e70042","DOI":"10.1002\/cph4.70042","volume":"15","author":"SQ Ding","year":"2025","unstructured":"Ding SQ, Lei Y, Zhao ZM, Li XY, Lang JX, Zhang JK, Li YS, Zhang CD, Dai DQ (2025) Crosstalk between microbiome and ferroptosis in diseases: from mechanism to therapy. Compr Physiol 15:e70042. https:\/\/doi.org\/10.1002\/cph4.70042","journal-title":"Compr Physiol"},{"key":"12639_CR79","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/carcin\/bgae064","volume":"45","author":"S Graham","year":"2024","unstructured":"Graham S, Dmitrieva M, Vendramini-Costa DB, Francescone R, Trujillo MA, Cukierman E, Wood LD (2024) From precursor to cancer: decoding the intrinsic and extrinsic pathways of pancreatic intraepithelial neoplasia progression. Carcinogenesis 45:801\u2013816. https:\/\/doi.org\/10.1093\/carcin\/bgae064","journal-title":"Carcinogenesis"},{"key":"12639_CR80","doi-asserted-by":"publisher","first-page":"757","DOI":"10.4251\/wjgo.v15.i5.757","volume":"15","author":"Q Lin","year":"2023","unstructured":"Lin Q, Guan SW, Yu HB (2023) Immuno-oncology-microbiome axis of gastrointestinal malignancy. World J Gastrointest Oncol 15:757\u2013775. https:\/\/doi.org\/10.4251\/wjgo.v15.i5.757","journal-title":"World J Gastrointest Oncol"},{"key":"12639_CR81","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, Quesada P, Sahin I, Chandra V, San Lucas A, Scheet P, Xu H, Hanash SM, Feng L, Burks JK, Do K-A, Peterson CB, Nejman D, Tzeng C-WD, Kim MP, Sears CL, Ajami N, Petrosino J, Wood LD, Maitra A, Straussman R, Katz M, White JR, Jenq R, Wargo J, McAllister F (2019) Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell 178:795\u2013806e12. https:\/\/doi.org\/10.1016\/j.cell.2019.07.008","journal-title":"Cell"},{"key":"12639_CR82","doi-asserted-by":"publisher","first-page":"101397","DOI":"10.1016\/j.xcrm.2024.101397","volume":"5","author":"Y Li","year":"2024","unstructured":"Li Y, Chang RB, Stone ML, Delman D, Markowitz K, Xue Y, Coho H, Herrera VM, Li JH, Zhang L, Choi-Bose S, Giannone M, Shin SM, Coyne EM, Hernandez A, Gross NE, Charmsaz S, Ho WJ, Lee JW, Beatty GL (2024) Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer. Cell Rep Med 5:101397. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101397","journal-title":"Cell Rep Med"},{"key":"12639_CR83","doi-asserted-by":"publisher","first-page":"713","DOI":"10.4251\/wjgo.v15.i5.713","volume":"15","author":"S-W Guan","year":"2023","unstructured":"Guan S-W, Lin Q, Yu H-B (2023) Intratumour microbiome of pancreatic cancer. World J Gastrointest Oncol 15:713\u2013730. https:\/\/doi.org\/10.4251\/wjgo.v15.i5.713","journal-title":"World J Gastrointest Oncol"},{"key":"12639_CR84","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.3390\/cancers13143431","volume":"13","author":"R Bellotti","year":"2021","unstructured":"Bellotti R, Speth C, Adolph TE, Lass-Fl\u00f6rl C, Effenberger M, \u00d6fner D, Maglione M (2021) Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma Development. Cancers (Basel) 13:3431. https:\/\/doi.org\/10.3390\/cancers13143431","journal-title":"Cancers (Basel)"},{"key":"12639_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers15010001","volume":"15","author":"C Binda","year":"2022","unstructured":"Binda C, Gibiino G, Sbrancia M, Coluccio C, Cazzato M, Carloni L, Cucchetti A, Ercolani G, Sambri V, Fabbri C (2022) Microbiota in the Natural History of Pancreatic Cancer: From Predisposition to Therapy. Cancers (Basel) 15:1. https:\/\/doi.org\/10.3390\/cancers15010001","journal-title":"Cancers (Basel)"},{"key":"12639_CR86","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1158\/0008-5472.CAN-24-0275","volume":"84","author":"R Zhang","year":"2024","unstructured":"Zhang R, Kang R, Tang D (2024) Gut Microbiome Mediates Ferroptosis Resistance for Colorectal Cancer Development. Cancer Res 84:796\u2013797. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-0275","journal-title":"Cancer Res"},{"key":"12639_CR87","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s13402-023-00831-8","volume":"46","author":"X Yang","year":"2023","unstructured":"Yang X, Zhang Z, Shen X, Xu J, Weng Y, Wang W, Xue J (2023) Clostridium butyricum and its metabolite butyrate promote ferroptosis susceptibility in pancreatic ductal adenocarcinoma. Cell Oncol (Dordr) 46:1645\u20131658. https:\/\/doi.org\/10.1007\/s13402-023-00831-8","journal-title":"Cell Oncol (Dordr)"},{"key":"12639_CR88","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.3390\/cancers12113234","volume":"12","author":"A Khomiak","year":"2020","unstructured":"Khomiak A, Brunner M, Kordes M, Lindblad S, Miksch RC, \u00d6hlund D, Regel I (2020) Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer. Cancers (Basel) 12:3234. https:\/\/doi.org\/10.3390\/cancers12113234","journal-title":"Cancers (Basel)"},{"key":"12639_CR89","doi-asserted-by":"publisher","first-page":"217456","DOI":"10.1016\/j.canlet.2025.217456","volume":"612","author":"P Li","year":"2025","unstructured":"Li P, Zhang H, Chen L, Gao X, Hu Y, Xu Q, Liu W, Chen W, Chen H, Yuan S, Wang M, Liu S, Dai M (2025) Oral and fecal microbiota as accurate non-invasive tools for detection of pancreatic cancer in the Chinese population. Cancer Lett 612:217456. https:\/\/doi.org\/10.1016\/j.canlet.2025.217456","journal-title":"Cancer Lett"},{"key":"12639_CR90","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/gutjnl-2011-300784","volume":"61","author":"JJ Farrell","year":"2012","unstructured":"Farrell JJ, Zhang L, Zhou H, Chia D, Elashoff D, Akin D, Paster BJ, Joshipura K, Wong DTW (2012) Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut 61:582\u2013588. https:\/\/doi.org\/10.1136\/gutjnl-2011-300784","journal-title":"Gut"},{"key":"12639_CR91","first-page":"3163","volume":"11","author":"H Matsukawa","year":"2021","unstructured":"Matsukawa H, Iida N, Kitamura K, Terashima T, Seishima J, Makino I, Kannon T, Hosomichi K, Yamashita T, Sakai Y, Honda M, Yamashita T, Mizukoshi E, Kaneko S (2021) Dysbiotic gut microbiota in pancreatic cancer patients form correlation networks with the oral microbiota and prognostic factors. Am J Cancer Res 11:3163\u20133175","journal-title":"Am J Cancer Res"},{"key":"12639_CR92","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/pathogens14010002","volume":"14","author":"DL D\u2019Antonio","year":"2025","unstructured":"D\u2019Antonio DL, Zenoniani A, Umme S, Piattelli A, Curia MC (2025) Intratumoral Fusobacterium nucleatum in pancreatic cancer: current and future perspectives. Pathogens 14:2. https:\/\/doi.org\/10.3390\/pathogens14010002","journal-title":"Pathogens"},{"key":"12639_CR93","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/carcin\/bgz116","volume":"41","author":"R Mendez","year":"2020","unstructured":"Mendez R, Kesh K, Arora N, Di Martino L, McAllister F, Merchant N, Banerjee S, Banerjee S (2020) Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer. Carcinogenesis 41:561\u2013570. https:\/\/doi.org\/10.1093\/carcin\/bgz116","journal-title":"Carcinogenesis"},{"key":"12639_CR94","doi-asserted-by":"publisher","first-page":"1487242","DOI":"10.3389\/fimmu.2024.1487242","volume":"15","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Liang X, Zhi M, Li L, Zhang G, Chen C, Wang L, Wang P, Zhong N, Feng Q, Li Z (2024) Succession of the multi-site microbiome along pancreatic ductal adenocarcinoma tumorigenesis. Front Immunol 15:1487242. https:\/\/doi.org\/10.3389\/fimmu.2024.1487242","journal-title":"Front Immunol"},{"issue":"15suppl","key":"12639_CR95","doi-asserted-by":"publisher","first-page":"4630","DOI":"10.1200\/jco.2009.27.15_suppl.4630","volume":"27","author":"DT Wong","year":"2009","unstructured":"Wong DT, Zhang L, Farrell J, Zhou H, Elashoff D, Gao K, Paster B (2009) Salivary biomarkers for pancreatic cancer detection. J Clin Oncol 27(15suppl):4630. https:\/\/doi.org\/10.1200\/jco.2009.27.15_suppl.4630","journal-title":"J Clin Oncol"},{"key":"12639_CR96","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jormas.2019.04.013","volume":"120","author":"J Sturque","year":"2019","unstructured":"Sturque J, Berquet A, Loison-Robert LS, Ahossi V, Zwetyenga N (2019) Interest of studying the saliva metabolome, transcriptome and microbiome in screening for pancreatic cancer. J Stomatol Oral Maxillofac Surg 120:554\u2013558. https:\/\/doi.org\/10.1016\/j.jormas.2019.04.013","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"12639_CR97","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","volume":"8","author":"S Pushalkar","year":"2018","unstructured":"Pushalkar S, Hundeyin M, Daley D, Zambirinis CP, Kurz E, Mishra A, Mohan N, Aykut B, Usyk M, Torres LE, Werba G, Zhang K, Guo Y, Li Q, Akkad N, Lall S, Wadowski B, Gutierrez J, Kochen Rossi JA, Herzog JW, Diskin B, Torres-Hernandez A, Leinwand J, Wang W, Taunk PS, Savadkar S, Janal M, Saxena A, Li X, Cohen D, Sartor RB, Saxena D, Miller G (2018) Microbiome promotes pancreatic cancer. Cancer Discov 8:403\u2013416. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-1134","journal-title":"Cancer Discov"},{"key":"12639_CR98","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1053\/j.gastro.2018.04.001","volume":"155","author":"V Sethi","year":"2018","unstructured":"Sethi V, Kurtom S, Tarique M, Lavania S, Malchiodi Z, Hellmund L, Zhang L, Sharma U, Giri B, Garg B, Ferrantella A, Vickers SM, Banerjee S, Dawra R, Roy S, Ramakrishnan S, Saluja A, Dudeja V (2018) Gut microbiota promotes tumor growth in mice by modulating immune response. Gastroenterology 155:33\u201337e6. https:\/\/doi.org\/10.1053\/j.gastro.2018.04.001","journal-title":"Gastroenterology"},{"key":"12639_CR99","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41420-023-01397-y","volume":"9","author":"C Panebianco","year":"2023","unstructured":"Panebianco C, Pisati F, Villani A, Andolfo A, Ulaszewska M, Bellini E, Ferro C, Lombardi R, Orsenigo F, Latiano TP, Belmonte B, Tripodo C, Perri F, Pazienza V (2023) Counteracting gemcitabine\u2009+\u2009nab-paclitaxel induced dysbiosis in KRAS wild type and KRASG12D mutated pancreatic cancer in vivo model. Cell Death Discov 9:116. https:\/\/doi.org\/10.1038\/s41420-023-01397-y","journal-title":"Cell Death Discov"},{"key":"12639_CR100","doi-asserted-by":"publisher","first-page":"113163","DOI":"10.1016\/j.biopha.2022.113163","volume":"151","author":"C Panebianco","year":"2022","unstructured":"Panebianco C, Villani A, Pisati F, Orsenigo F, Ulaszewska M, Latiano TP, Potenza A, Andolfo A, Terracciano F, Tripodo C, Perri F, Pazienza V (2022) Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models. Biomed Pharmacother 151:113163. https:\/\/doi.org\/10.1016\/j.biopha.2022.113163","journal-title":"Biomed Pharmacother"},{"key":"12639_CR101","doi-asserted-by":"publisher","first-page":"11070","DOI":"10.1038\/s41598-021-90707-4","volume":"11","author":"H Konishi","year":"2021","unstructured":"Konishi H, Isozaki S, Kashima S, Moriichi K, Ichikawa S, Yamamoto K, Yamamura C, Ando K, Ueno N, Akutsu H, Ogawa N, Fujiya M (2021) Probiotic Aspergillus oryzae produces anti-tumor mediator and exerts anti-tumor effects in pancreatic cancer through the p38 MAPK signaling pathway. Sci Rep 11:11070. https:\/\/doi.org\/10.1038\/s41598-021-90707-4","journal-title":"Sci Rep"},{"key":"12639_CR102","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","volume":"8","author":"S Pushalkar","year":"2018","unstructured":"Pushalkar S, Hundeyin M, Daley D, Zambirinis CP, Kurz E, Mishra A, Mohan N, Aykut B, Usyk M, Torres LE, Werba G, Zhang K, Guo Y, Li Q, Akkad N, Lall S, Wadowski B, Gutierrez J, Rossi JAK, Herzog JW, Diskin B, Torres-Hernandez A, Leinwand J, Wang W, Taunk PS, Savadkar S, Janal M, Saxena A, Li X, Cohen D, Sartor RB, Saxena D, Miller G (2018) The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov 8:403\u2013416. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-1134","journal-title":"Cancer Discov"},{"key":"12639_CR103","doi-asserted-by":"publisher","first-page":"1456030","DOI":"10.3389\/fimmu.2024.1456030","volume":"15","author":"S Lu","year":"2024","unstructured":"Lu S, Wang C, Ma J, Wang Y (2024) Metabolic mediators: microbial-derived metabolites as key regulators of anti-tumor immunity, immunotherapy, and chemotherapy. Front Immunol 15:1456030. https:\/\/doi.org\/10.3389\/fimmu.2024.1456030","journal-title":"Front Immunol"},{"key":"12639_CR104","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","volume":"615","author":"J Tintelnot","year":"2023","unstructured":"Tintelnot J, Xu Y, Lesker TR, Sch\u00f6nlein M, Konczalla L, Giannou AD, Pelczar P, Kylies D, Puelles VG, Bielecka AA, Peschka M, Cortesi F, Riecken K, Jung M, Amend L, Br\u00f6ring TS, Trajkovic-Arsic M, Siveke JT, Renn\u00e9 T, Zhang D, Boeck S, Strowig T, Uzunoglu FG, G\u00fcng\u00f6r C, Stein A, Izbicki JR, Bokemeyer C, Sinn M, Kimmelman AC, Huber S, Gagliani N (2023) Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature 615:168\u2013174. https:\/\/doi.org\/10.1038\/s41586-023-05728-y","journal-title":"Nature"},{"key":"12639_CR105","doi-asserted-by":"publisher","first-page":"eabn0704","DOI":"10.1126\/sciimmunol.abn0704","volume":"7","author":"G Mirji","year":"2022","unstructured":"Mirji G, Worth A, Bhat SA, El Sayed M, Kannan T, Goldman AR, Tang HY, Liu Q, Auslander N, Dang CV, Abdel-Mohsen M, Kossenkov A, Stanger BZ, Shinde RS (2022) The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer. Sci Immunol 7:eabn0704. https:\/\/doi.org\/10.1126\/sciimmunol.abn0704","journal-title":"Sci Immunol"},{"issue":"13Suppl","key":"12639_CR106","doi-asserted-by":"publisher","first-page":"B24","DOI":"10.1158\/1538-7445.PANCA19-B24","volume":"79","author":"SK Highlander","year":"2019","unstructured":"Highlander SK, Chung V, Alistar AT, Borazanci E, Jameson G, Pearson T, Cantafio NA, Hoff DDV (2019) Abstract B24: Gastrointestinal microbiome changes in stage IV pancreatic cancer patients treated with pembrolizumab with or without paricalcitol on the Stand Up to Cancer (SU2C) Pancreas Catalyst Trial. Cancer Res 79(13Suppl):B24. https:\/\/doi.org\/10.1158\/1538-7445.PANCA19-B24","journal-title":"Cancer Res"},{"key":"12639_CR107","doi-asserted-by":"publisher","first-page":"2035659","DOI":"10.1080\/19490976.2022.2035659","volume":"14","author":"K Ka\u017amierczak-Siedlecka","year":"2022","unstructured":"Ka\u017amierczak-Siedlecka K, Skonieczna-\u017bydecka K, Hupp T, Duchnowska R, Marek-Trzonkowska N, Po\u0142om K (2022) Next-generation probiotics: do they open new therapeutic strategies for cancer patients? Gut Microbes 14:2035659. https:\/\/doi.org\/10.1080\/19490976.2022.2035659","journal-title":"Gut Microbes"},{"key":"12639_CR108","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1158\/0008-5472.CAN-23-0605","volume":"83","author":"Y Gao","year":"2023","unstructured":"Gao Y, Xu P, Sun D, Jiang Y, Lin XL, Han T, Yu J, Sheng C, Chen H, Hong J, Chen Y, Xiao XY, Fang JY (2023) Faecalibacterium prausnitzii abrogates intestinal toxicity and promotes tumor immunity to increase the efficacy of dual CTLA4 and PD-1 checkpoint blockade. Cancer Res 83:3710\u20133725. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0605","journal-title":"Cancer Res"},{"key":"12639_CR109","doi-asserted-by":"publisher","first-page":"8608","DOI":"10.1021\/acs.nanolett.2c03131","volume":"22","author":"ZY Han","year":"2022","unstructured":"Han ZY, Chen QW, Fu ZJ, Cheng SX, Zhang XZ (2022) Probiotic spore-based oral drug delivery system for enhancing pancreatic cancer chemotherapy by gut-pancreas-axis-guided delivery. Nano Lett 22:8608\u20138617. https:\/\/doi.org\/10.1021\/acs.nanolett.2c03131","journal-title":"Nano Lett"},{"key":"12639_CR110","doi-asserted-by":"publisher","first-page":"116218","DOI":"10.1016\/j.biopha.2024.116218","volume":"172","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Tang N, Zhou H, Zhu Y (2024) The role of microbial metabolites in endocrine tumorigenesis: from mechanistic insights to potential therapeutic biomarkers. Biomed Pharmacother 172:116218. https:\/\/doi.org\/10.1016\/j.biopha.2024.116218","journal-title":"Biomed Pharmacother"},{"key":"12639_CR111","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12934-020-01330-3","volume":"19","author":"K Kesh","year":"2020","unstructured":"Kesh K, Mendez R, Abdelrahman L, Banerjee S, Banerjee S (2020) Type 2 diabetes-induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma. Microb Cell Fact 19:75. https:\/\/doi.org\/10.1186\/s12934-020-01330-3","journal-title":"Microb Cell Fact"},{"key":"12639_CR112","doi-asserted-by":"publisher","first-page":"887383","DOI":"10.3389\/fonc.2022.887383","volume":"12","author":"Z Wu","year":"2022","unstructured":"Wu Z, Zhang S, Li L, Huang Z, Huang D, Hu Y (2022) The gut microbiota modulates responses to anti-PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumors. Front Oncol 12:887383. https:\/\/doi.org\/10.3389\/fonc.2022.887383","journal-title":"Front Oncol"},{"key":"12639_CR113","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/carcin\/bgy073","volume":"39","author":"RM Thomas","year":"2018","unstructured":"Thomas RM, Gharaibeh RZ, Gauthier J, Beveridge M, Pope JL, Guijarro MV, Yu Q, He Z, Ohland C, Newsome R, Trevino J, Hughes SJ, Reinhard M, Winglee K, Fodor AA, Zajac-Kaye M, Jobin C (2018) Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models. Carcinogenesis 39:1068\u20131078. https:\/\/doi.org\/10.1093\/carcin\/bgy073","journal-title":"Carcinogenesis"},{"key":"12639_CR114","doi-asserted-by":"publisher","first-page":"2447821","DOI":"10.1080\/19490976.2024.2447821","volume":"17","author":"B Luo","year":"2025","unstructured":"Luo B, An Q, Lei J, Tan D, Liu X, Li H, Zhao Y, Qin J, Zhang C, Zhang Y, Shi C (2025) Resveratrol amplifies the anti-tumor effect of \u03b1-PD-1 by altering the intestinal microbiome and PGD2 content. Gut Microbes 17:2447821. https:\/\/doi.org\/10.1080\/19490976.2024.2447821","journal-title":"Gut Microbes"},{"key":"12639_CR115","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.3748\/wjg.v16.i28.3546","volume":"16","author":"C Maletzki","year":"2010","unstructured":"Maletzki C, Gock M, Klier U, Klar E, Linnebacher M (2010) Bacteriolytic therapy of experimental pancreatic carcinoma. World J Gastroenterol 16:3546\u20133552. https:\/\/doi.org\/10.3748\/wjg.v16.i28.3546","journal-title":"World J Gastroenterol"},{"key":"12639_CR116","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/gut.2007.125419","volume":"57","author":"C Maletzki","year":"2008","unstructured":"Maletzki C, Linnebacher M, Kreikemeyer B, Emmrich J (2008) Pancreatic cancer regression by intratumoural injection of live Streptococcus pyogenes in a syngeneic mouse model. Gut 57:483\u2013491. https:\/\/doi.org\/10.1136\/gut.2007.125419","journal-title":"Gut"},{"key":"12639_CR117","volume-title":"Changing the pancreatic cancer treatment paradigm: developing Clostridium novyi as an intravenously injectable solid-state tumor therapeutic","author":"KM Dailey","year":"2020","unstructured":"Dailey KM (2020) Changing the pancreatic cancer treatment paradigm: developing Clostridium novyi as an intravenously injectable solid-state tumor therapeutic. North Dakota State University, Fargo, ND, USA. Doctoral dissertation"},{"key":"12639_CR118","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41575-025-01119-y","volume":"22","author":"RM Thomas","year":"2025","unstructured":"Thomas RM (2025) Multifaceted effects of the microbiome in pancreatic cancer: from association to modulation. Nat Rev Gastroenterol Hepatol 22:829\u2013845. https:\/\/doi.org\/10.1038\/s41575-025-01119-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"12639_CR119","unstructured":"M.D. Anderson Cancer Center Pilot study using fecal microbial transplants in patients with pancreatic cancer. ClinicalTrials.gov. Identifier: NCT04975217"},{"key":"12639_CR120","unstructured":"Lenehan J (2025) An open-label, single-arm, phase 1 study of the combination of FMT and gemcitabine with nab-paclitaxel as first-line therapy in patients with advanced pancreatic ductal adenocarcinoma. ClinicalTrials.gov. Identifier: NCT06393400"},{"key":"12639_CR121","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nrgastro.2016.98","volume":"13","author":"A Khoruts","year":"2016","unstructured":"Khoruts A, Sadowsky MJ (2016) Understanding the mechanisms of faecal microbiota transplantation. Nat Rev Gastroenterol Hepatol 13:508\u2013516. https:\/\/doi.org\/10.1038\/nrgastro.2016.98","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"12639_CR122","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10555-021-09982-2","volume":"40","author":"JJ Li","year":"2021","unstructured":"Li JJ, Zhu M, Kashyap PC, Chia N, Tran NH, McWilliams RR, Bekaii-Saab TS, Ma WW (2021) The role of microbiome in pancreatic cancer. Cancer Metastasis Rev 40:777\u2013789. https:\/\/doi.org\/10.1007\/s10555-021-09982-2","journal-title":"Cancer Metastasis Rev"},{"key":"12639_CR123","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12915-014-0087-z","volume":"12","author":"SJ Salter","year":"2014","unstructured":"Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, Turner P, Parkhill J, Loman NJ, Walker AW (2014) Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol 12:87. https:\/\/doi.org\/10.1186\/s12915-014-0087-z","journal-title":"BMC Biol"},{"key":"12639_CR124","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tim.2018.11.003","volume":"27","author":"R Eisenhofer","year":"2019","unstructured":"Eisenhofer R, Minich JJ, Marotz C, Cooper A, Knight R, Weyrich LS (2019) Contamination in low microbial biomass microbiome studies: issues and recommendations. Trends Microbiol 27:105\u2013117. https:\/\/doi.org\/10.1016\/j.tim.2018.11.003","journal-title":"Trends Microbiol"},{"key":"12639_CR125","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","volume":"4","author":"SR Hingorani","year":"2003","unstructured":"Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, Ross S, Conrads TP, Veenstra TD, Hitt BA, Kawaguchi Y, Johann D, Liotta LA, Crawford HC, Putt ME, Jacks T, Wright CVE, Hruban RH, Lowy AM, Tuveson DA (2003) Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4:437\u2013450. https:\/\/doi.org\/10.1016\/S1535-6108(03)00309-X","journal-title":"Cancer Cell"},{"key":"12639_CR126","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semcancer.2025.03.002","volume":"112","author":"N Daniel","year":"2025","unstructured":"Daniel N, Farinella R, Belluomini F, Fajkic A, Rizzato C, Sou\u010dek P, Campa D, Hughes DJ (2025) The relationship of the microbiome, associated metabolites and the gut barrier with pancreatic cancer. Semin Cancer Biol 112:43\u201357. https:\/\/doi.org\/10.1016\/j.semcancer.2025.03.002","journal-title":"Semin Cancer Biol"},{"key":"12639_CR127","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.4142\/jvs.2020.21.e26","volume":"21","author":"YJ Chang","year":"2020","unstructured":"Chang YJ, Bae J, Zhao Y, Lee G, Han J, Lee YH, Koo OJ, Seo S, Choi YK, Yeom SC (2020) In vivo multiplex gene targeting with Streptococcus pyogenes and Campylobacter jejuni Cas9 for pancreatic cancer modeling in wild-type animals. J Vet Sci 21:e26. https:\/\/doi.org\/10.4142\/jvs.2020.21.e26","journal-title":"J Vet Sci"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12639-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12639-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12639-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:30:14Z","timestamp":1787653814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12639-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":127,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12639"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12639-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1455"}}